General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board

General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix 
Industry Veteran and Authority on Patent Law and Valuation Joins
Spherix as Director 
TYSONS CORNER, VA -- (Marketwired) -- 10/29/13 --   Spherix
Incorporated (NASDAQ: SPEX), an intellectual property development
company committed to the fostering and monetization of intellectual
property, announced today that Alexander Poltorak has been appointed
to Spherix's Board of Directors, effective October 28, 2013. 
"We are very pleased that Alex accepted our invitation to join
Spherix's board," said Spherix's CEO and President, Anthony Hayes.
"Alex's extensive experience in the patent monetization industry will
provide valuable governance leadership to Spherix. He will be a great
addition to our board. We are excited and privileged to have Alex
join our board." 
Alexander Poltorak is the Founder, Chairman and the CEO of General
Patent Corporation (GPC), a leading intellectual property firm
focusing on IP strategy and valuation, IP licensing and enforcement
-- the oldest such organization in the world. He also serves as the
Managing Director of IP Holdings LLC, an IP-centric merchant banking
boutique providing IP-focused financial, brokerage and advisory
services, and operating an idea incubator. Alexander Poltorak was
listed among world leading IP strategists by IAM Magazine in 2010,
2011 and 2012. Dr. Poltorak has co-authored two books, Essentials of
Intellectual Property (John Wiley & Sons Publishers, Inc., 2d ed.
2011), and Essentials of Licensing Intellectual Property (John Wiley
& Sons Publishers, Inc., 2004), and contributed a chapter to Making
Innovation Pay - Turning IP into Shareholder Value (John Wiley & Sons
Publishers, Inc., 2006). He also authored numerous articles on patent
law, licensing and economics. He served on the editorial board of
Patent Strategy & Management.  
Prior to establishing GPC in 1987, Alex Poltorak was President and
CEO of Rapitech Systems, Inc., a computer technology company that he
had founded in 1983 and took public in 1986. Before that, he served
as Assistant Professor of Biomathematics at the Neurology Department
of Cornell University Medical College. He also served as Assistant
Professor of Physics at Touro College. Dr. Poltorak has published
papers in peer-reviewed scientific journals. Alexander Poltorak
taught business law as Adjunct Professor at the Globe Institute of
Technology. He was a regular guest-lecturer on intellectual property
law and economics at the Columbia University School of Business and
School of Engineering. 
Dr. Poltorak is the Founder and Chairman of an industry association,
American Innovators for Patent Reform (AIPR). He was US Co-chair of
the subcommittee on Information Exchange of the US-USSR Trade and
Economic Counsel.  
About Spherix 
 Spherix Incorporated was launched in 1967 as a
scientific research company. Spherix presently offers a diversified
commercialization platform for protected technologies. The company
continues to work on life sciences and drug development and presently
is exploring opportunities in nutritional supplement products relying
on its D-Tagatose natural sweetener as a GRAS ingredient. Spherix is
committed to advancing innovation by active participation in all
areas of the patent market. Spherix draws on portfolios of pioneering
technology patents to partner with and support product innovation.
Through its recently announced acquisition of several hundred patents
issued to Harris Corporation Spherix intends to expand its activities
in wireless communications and telecommunication sectors including
antenna technology, Wi-Fi, base station functionality, and cellular. 
Forward Looking Statements
 Certain statements in this press release
constitute "forward-looking statements" within the meaning of the
federal securities laws. Words such as "may," "might," "will,"
"should," "believe," "expect," "anticipate," "estimate," "continue,"
"predict," "forecast," "project," "plan," "intend" or similar
expressions, or statements regarding intent, belief, or current
expectations, are forward-looking statements. While the Company
believes these forward-looking statements are reasonable, undue
reliance should not be placed on any such forward-looking statements,
which are based on information available to us on the date of this
release. These forward looking statements are based upon current
estimates and assumptions and are subject to various risks and
uncertainties, including without limitation those set forth in the
Company's filings with the Securities and Exchange Commission (the
"SEC"), not limited to Risk Factors relating to its patent business
contained therein. Thus, actual results could be materially
different. The Company expressly disclaims any obligation to update
or alter statements whether as a result of new information, future
events or otherwise, except as required by law. 
Investor Relations 
Phone: (703) 992-9325
Press spacebar to pause and continue. Press esc to stop.